High Content Image Analysis of Spatiotemporal Proliferation and Differentiation Patterns in 3D Embryoid Body Differentiation Model.

3D cell models Developmental toxicity Embryoid body Embryonic stem cells High content image analysis

Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2022
Historique:
pubmed: 8 5 2021
medline: 28 7 2022
entrez: 7 5 2021
Statut: ppublish

Résumé

The 3D embryoid body (EB) differentiation model is a promising tool for fundamental cell biology and drug discovery studies assessing the compound effects on mammalian and human development. This 3D cell model allows for analyzing spatiotemporal changes during morphogenesis and differentiation. A combination of confocal microscopy with high content image analysis (HCIA) can significantly improve the study of spatiotemporal patterns of early embryonic lineages and compound efficacy and toxicity testing by enhancing the identification and quantification of various cell types. HCIA can be used to assess the EB architecture through quantitative and qualitative characteristics, such as viability and apoptosis, identification, localization, ratio and timing for various types of early embryonic cells, dimensions of compartments of proliferating and differentiating cells, changes in the size and shape of EBs, and translocation of individual cells and cell layers. This chapter describes a comprehensive framework for HCIA for 3D EB differentiation model that allows investigators to analyze EB growth, differentiation, and morphogenetic dynamics.

Identifiants

pubmed: 33959918
doi: 10.1007/7651_2021_405
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-79

Informations de copyright

© 2021. Springer Science+Business Media, LLC.

Références

Ebert AD, Svendsen CN (2010) Human stem cells and drug screening: opportunities and challenges. Nat Rev Drug Discov 9:367–372. https://doi.org/10.1038/nrd3000
doi: 10.1038/nrd3000 pubmed: 20339370
Avior Y, Sagi I, Benvenisty N (2016) Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol 17:170–182
doi: 10.1038/nrm.2015.27 pubmed: 26818440
Rowe RG, Daley GQ (2019) Induced pluripotent stem cells in disease modelling and drug discovery. Nat Rev Genet 20:377–388
doi: 10.1038/s41576-019-0100-z pubmed: 30737492 pmcid: 6584039
Lauschke K, Rosenmai AK, Meiser I et al (2020) A novel human pluripotent stem cell-based assay to predict developmental toxicity. Arch Toxicol 94:3831–3846. https://doi.org/10.1007/s00204-020-02856-6
doi: 10.1007/s00204-020-02856-6 pubmed: 32700165 pmcid: 7603451
Dutta D, Heo I, Clevers H (2017) Disease modeling in stem cell-derived 3D organoid systems. Trends Mol Med 23:393–410
doi: 10.1016/j.molmed.2017.02.007 pubmed: 28341301
Takahashi T (2019) Organoids for drug discovery and personalized medicine. Annu Rev Pharmacol Toxicol 59:447–462
doi: 10.1146/annurev-pharmtox-010818-021108 pubmed: 30113875
O’Connell L, Winter DC (2020) Organoids: past learning and future directions. Stem Cells Dev 29:281–289
doi: 10.1089/scd.2019.0227 pubmed: 31805828
Clevers H (2016) Modeling development and disease with organoids. Cell 165:1586–1597
doi: 10.1016/j.cell.2016.05.082 pubmed: 27315476
Flamier A, Singh S, Rasmussen TP (2017) A standardized human embryoid body platform for the detection and analysis of teratogens. PLoS One 12:e0171101. https://doi.org/10.1371/journal.pone.0171101
doi: 10.1371/journal.pone.0171101 pubmed: 28182681 pmcid: 5300235
Kim J, Koo BK, Knoblich JA (2020) Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol 21:571–584
doi: 10.1038/s41580-020-0259-3 pubmed: 32636524 pmcid: 7339799
Kang HY, Choi YK, Jo NR et al (2017) Advanced developmental toxicity test method based on embryoid body’s area. Reprod Toxicol 72:74–85. https://doi.org/10.1016/j.reprotox.2017.06.185
doi: 10.1016/j.reprotox.2017.06.185 pubmed: 28673813
Warkus ELL, Yuen AAYQ, Lau CGY, Marikawa Y (2016) Use of in vitro morphogenesis of mouse embryoid bodies to assess developmental toxicity of therapeutic drugs contraindicated in pregnancy. Toxicol Sci 149:15–30. https://doi.org/10.1093/toxsci/kfv209
doi: 10.1093/toxsci/kfv209 pubmed: 26385866
Gordeeva O, Gordeev A (2021) Comparative assessment of toxic responses in 3D embryoid body differentiation model and mouse early embryos treated with 5-hydroxytryptophan. Arch Toxicol 95:253–269. https://doi.org/10.1007/s00204-020-02909-w
doi: 10.1007/s00204-020-02909-w pubmed: 32926198
De Bernardi MA, Hewitt SM, Kriete A (2006) Automated confocal imaging and high-content screening for cytomics. In: Handbook of biological confocal microscopy, 3rd edn. Springer, New York, pp 809–817
doi: 10.1007/978-0-387-45524-2_46
Sirenko O, Hancock MK, Crittenden C et al (2017) Phenotypic assays for characterizing compound effects on induced pluripotent stem cell-derived cardiac spheroids. Assay Drug Dev Technol 15:280–296. https://doi.org/10.1089/adt.2017.792
doi: 10.1089/adt.2017.792 pubmed: 28837356
Chandrasekaran SN, Ceulemans H, Boyd JD, Carpenter AE (2021) Image-based profiling for drug discovery: due for a machine-learning upgrade? Nat Rev Drug Discov 20:145–159
doi: 10.1038/s41573-020-00117-w pubmed: 33353986
Nagy A, Rossant J, Nagy R et al (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 90:8424–8428. https://doi.org/10.1073/pnas.90.18.8424
doi: 10.1073/pnas.90.18.8424 pubmed: 8378314 pmcid: 47369
Robertson E, Bradley A, Kuehn M, Evans M (1986) Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323:445–448. https://doi.org/10.1038/323445a0
doi: 10.1038/323445a0 pubmed: 3762693
Salic A, Mitchison TJ (2008) A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci U S A 105:2415–2420. https://doi.org/10.1073/pnas.0712168105
doi: 10.1073/pnas.0712168105 pubmed: 18272492 pmcid: 2268151

Auteurs

Olga Gordeeva (O)

Laboratory of Cell and Molecular Mechanisms of Histogenesis, Kol'tsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH